Drugs / Brinzolamide/Brimonidine
last change Jul 2017 re-read 9 days ago

Brinzolamide/Brimonidine

Developed for
ocular hypertension

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
Phase 4 NCT03192826 Comparator Jun 2016 → Jul 2017 lens disorder, ocular hypertension University Hospital of Patras Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Brinzolamide/Brimonidine ClinicalTrials.gov intervention name — accepted as the source's own label NCT03192826 ↗